Phil Tennant insider trades
Open-market stock purchases and sales by Phil Tennant, Chief Commercial Officer at Precigen, Inc, from SEC Form 4 filings since Jul 22, 2024.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +78%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 25, 2026 | PGEN Precigen, Inc | Sold | $594K |
| Aug 25, 2026 | PGEN Precigen, Inc | Bought (not open market) | $127K |
| Aug 25, 2026 | PGEN Precigen, Inc | Bought (not open market) | — |
| Aug 23, 2026 | PGEN Precigen, Inc | Bought (not open market) | — |
| Aug 23, 2026 | PGEN Precigen, Inc | Sold (not open market) | $18.6K |
| Aug 23, 2026 | PGEN Precigen, Inc | Bought (not open market) | — |
| May 28, 2026 | PGEN Precigen, Inc | Sold | $132K |
| May 23, 2026 | PGEN Precigen, Inc | Bought (not open market) | — |
| Apr 20, 2026 | PGEN Precigen, Inc | Bought (not open market) | — |
| Apr 20, 2026 | PGEN Precigen, Inc | Bought (not open market) | — |
| Mar 18, 2026 | PGEN Precigen, Inc | Bought (not open market) | — |
| Mar 18, 2026 | PGEN Precigen, Inc | Bought (not open market) | — |
Companies traded
- PGEN Precigen, Inc: 1 buy, 2 sales, last Aug 25, 2026